Scott Deeter joins Iteris' Board of Directors

Iteris, Inc. recently announced that Scott Deeter, president and CEO of Ventria, has been elected to its Board of Directors.

Deeter has served as Ventria's President and CEO and as a director since 2002. Ventria is the first company to commercialize recombinant proteins derived from a plant-based manufacturing system.

"We are very pleased for Scott to join Iteris as an independent director," said Tom Thomas, Chairman of the Board for Iteris. "Our entire board is impressed with Scott's proven business acumen and insights into emerging markets for technology, as well as his broad understanding of the agriculture value chain. As a highly regarded entrepreneur, Scott will contribute substantial value to Iteris, drawing on his extensive background in pioneering and commercializing new technologies."

"Iteris ClearAg delivers science-based insights to make agriculture more sustainable and productive," said Deeter. "There is a profound need to optimize the use of farmland to generate food, fiber and fuel for billions of people now and in the future. ClearAg, which is used by growers, crop scientists, and field service personnel around the world, is uniquely positioned to address this critical challenge."

Prior to Ventria, Deeter served as President and CEO and as a director of CyberCrop, a supply chain software company connecting producers with their markets to optimize quality, logistics and efficiency. Previously, Mr. Deeter started and led a joint venture between Cargill and F. Hoffmann-La Roche that commercialized pharmaceutical intermediates and functional food ingredients. Earlier in his career he was a member of the Technology and Life Sciences Group of Salomon Brothers. He is a graduate of the University of Kansas (BSc-Economics); University of Chicago (MBA); and London School of Economics (MSc-Economics).